Invesco Mutual Fund decreased its stake in Innova Captab Limited from 2.76% to 1.24%, selling 872,121 shares. The value of the sold shares is ₹83.97 Cr at a share price of ₹962.70.
An integrated pharmaceutical company operating across India's drug manufacturing and distribution value chain. Innova Captab develops, manufactures, and markets a diverse portfolio of pharmaceutical formulations for both domestic and international markets. The company maintains vertically integrated operations spanning multiple therapeutic areas, enabling control over production processes, quality management, and supply chain efficiency within the competitive Indian pharmaceutical sector.
Indian subsidiary of Invesco Ltd, a US-listed global investment manager with over USD 1.8 trillion in AUM worldwide. Manages over Rs 1.2 lakh crore in India. Known for its Invesco India Contra Fund, which runs a contrarian, undervalued stock strategy against consensus market positioning. One of the few global AMC franchises maintaining a strong active equity presence in India.
